Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

Clinical trial NCT06123286 · RECRUITING

Trial details

NCT number: NCT06123286
Sponsor: Philip Chang
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)Joint Pain

Start date: 2025-09-12
Primary completion: 2027-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.